Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2 as the current revision, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:21:27.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This update does not change the study information shown on the page.
    Difference
    0.0%
    Check dated 2026-03-18T22:56:00.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T20:02:31.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A new site revision label Revision: v3.4.2 was added, and older revision notices (Revision: v3.4.1) along with a government-funding notice were removed. These are administrative changes that do not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:33:36.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a government funding status notice about potential delays and the NIH open status. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:36:41.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page adds a glossary display option and updates QC metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T21:12:20.000Z thumbnail image

Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.